Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA
- PMID: 33547453
- DOI: 10.1038/s41562-021-01056-1
Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA
Erratum in
-
Author Correction: Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA.Nat Hum Behav. 2021 Mar;5(3):407. doi: 10.1038/s41562-021-01088-7. Nat Hum Behav. 2021. PMID: 33686205 Free PMC article. No abstract available.
-
Author Correction: Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA.Nat Hum Behav. 2021 Jul;5(7):960. doi: 10.1038/s41562-021-01172-y. Nat Hum Behav. 2021. PMID: 34239082 Free PMC article. No abstract available.
Abstract
Widespread acceptance of a vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will be the next major step in fighting the coronavirus disease 2019 (COVID-19) pandemic, but achieving high uptake will be a challenge and may be impeded by online misinformation. To inform successful vaccination campaigns, we conducted a randomized controlled trial in the UK and the USA to quantify how exposure to online misinformation around COVID-19 vaccines affects intent to vaccinate to protect oneself or others. Here we show that in both countries-as of September 2020-fewer people would 'definitely' take a vaccine than is likely required for herd immunity, and that, relative to factual information, recent misinformation induced a decline in intent of 6.2 percentage points (95th percentile interval 3.9 to 8.5) in the UK and 6.4 percentage points (95th percentile interval 4.0 to 8.8) in the USA among those who stated that they would definitely accept a vaccine. We also find that some sociodemographic groups are differentially impacted by exposure to misinformation. Finally, we show that scientific-sounding misinformation is more strongly associated with declines in vaccination intent.
References
-
- Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C. & Garry, R. F. The proximal origin of SARS-CoV-2. Nat. Med. 26, 450–452 (2020). - DOI
-
- Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020). - DOI
-
- World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020 https://www.who.int/director-general/speeches/detail/who-director-genera... (2020).
-
- Jackson, L. A. et al. An mRNA vaccine against SARS-CoV-2—preliminary report. N. Engl. J. Med. 383, 1920–1931 (2020). - DOI
-
- Mulligan, M. J. et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586, 589–593 (2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous